Compare Pfizer Inc (PFE) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Valero Energy Corporation — how do they compare? Pfizer Inc trades at $27.74 (market cap $159.59B), while Valero Energy Corporation trades at $443.1 (market cap $122.11B). The key difference: Pfizer Inc is the larger of the two by market cap, and Pfizer Inc pays the higher dividend (6.14%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Valero Energy Corporation for 56 Days on average.
| PFE | VLO | |
|---|---|---|
Market Cap | $159.59B | $122.11B |
Volume | 30,937,010 | 1,826,747 |
Sector | Health | Energy |
52-Week High | $29.02 | $443.80 |
52-Week Low | $23.67 | $156.39 |
Typical Hold Time | 158 Days | 56 Days |
Enterprise Value | $211.09B | $125.59B |
Dividend Yield | 6.14% | 1.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
Valero Energy (VLO) trades at $443.80, up 5.86% today and near its 52-week high, supported by bullish technical signals and strong earnings beats. Recent quarters have exceeded EPS expectations, with Q2 2026 EPS of $12.54 beating the $10.11 forecast. The stock shows robust profitability with a 29.31% ROE and trades at a P/E of 17.69, below the sector average. Positive news flow highlights refining margin strength and institutional interest.
The outlook remains positive given earnings momentum and favorable analyst sentiment, though risks include potential diesel export policy changes and volatile energy markets. Revenue is projected to rebound to $139.4B in 2026, driving net income higher. Investors should weigh solid fundamentals against sector-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
